Clinical Trial Update: Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

View source ↗

Summary

Expanded Access Protocol (EAP) for nonconforming Afami-cel is available for patients with synovial sarcoma or myxoid liposarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myxoid Liposarcoma
• Synovial Sarcoma

Drugs mentioned

• Afami-cel

Snippet

Sponsor: USWM CT, LLC | Conditions: Synovial Sarcoma, Myxoid Liposarcoma | Status: AVAILABLE